Skip to Content

9 3 5214 (Hydrochlorothiazide and Moexipril Hydrochloride 12.5 mg / 15 mg)

Pill with imprint 9 3 5214 is White, Elliptical / Oval and has been identified as Hydrochlorothiazide and Moexipril Hydrochloride 12.5 mg / 15 mg. It is supplied by Teva Pharmaceuticals USA.

Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 12.5 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 9 3 5214

Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 15 mg 9 3 5214 Front
Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 15 mg 9 3 5214 Back
Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 15 mg 9 3 5214
Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 15 mg 9 3 5214
Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 15 mg 9 3 5214

Hydrochlorothiazide and Moexipril Hydrochloride

Imprint
9 3 5214
Strength
12.5 mg / 15 mg
Color
White
Size
13.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Ace inhibitors with thiazides
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA

Labelers / Repackagers

NDC Code Labeler / Repackager
00093-5214 Teva Pharmaceuticals USA, Inc.
42291-0577 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.